首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Development of Conventional and Real-Time Nucleic Acid Sequence-Based Amplification Assays for Detection of Chlamydophila pneumoniae in Respiratory Specimens
【2h】

Development of Conventional and Real-Time Nucleic Acid Sequence-Based Amplification Assays for Detection of Chlamydophila pneumoniae in Respiratory Specimens

机译:基于常规和实时核酸序列的扩增样品在呼吸道标本中检测肺炎衣原体的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Isothermal nucleic acid sequence-based amplification (NASBA) was applied to the detection of Chlamydophila pneumoniae 16S rRNA by using the NucliSens basic kit (bioMérieux, Boxtel, The Netherlands). The assay was originally developed as a conventional NASBA assay with electrochemiluminescence detection and was subsequently adapted to a real-time NASBA format by using a molecular beacon. C. pneumoniae RNA prepared from a plasmid construct was used to assess the analytical sensitivity of the assay. The sensitivity of the NASBA assay was 10 molecules of in vitro wild-type C. pneumoniae RNA and 0.1 inclusion-forming unit (IFU) of C. pneumoniae. In spiked respiratory specimens, the sensitivity of the C. pneumoniae NASBA assay varied between 0.1 and 1 IFU/100 μl sample, depending on the type of specimen. Finally, conventional and real-time NASBA were applied to respiratory specimens previously tested by PCR. A 100% concordance between the test results was obtained.
机译:通过使用NucliSens基本试剂盒(bioMérieux,Boxtel,荷兰),将基于等温核酸序列的扩增(NASBA)用于肺炎衣原体16S rRNA的检测。该检测方法最初开发为具有化学发光检测的常规NASBA检测方法,随后通过使用分子信标使其适应实时NASBA格式。由质粒构建体制备的肺炎衣原体RNA用于评估测定的分析灵敏度。 NASBA测定的灵敏度为10个分子的野生野生型肺炎衣原体RNA和0.1个肺炎衣原体包涵体形成单位(IFU)。在加标的呼吸道样本中,取决于样本的类型,肺炎衣原体NASBA测定的灵敏度在0.1和1 IFU / 100μl样本之间变化。最后,将常规和实时NASBA应用于先前通过PCR测试的呼吸道标本。测试结果之间获得100%的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号